Table 5 Results of the ROC analysis.
Modalities | AUC | 95% CI | Youden thresholds | Sensitivity (%) | Specificity (%) |
|---|---|---|---|---|---|
\(\widetilde{{{\mbox{T}}}2}\) | 0.48 (0.49) | 38–58 (41–57) | 0.90 (0.90) | 78 (72) | 35 (35) |
\(\widetilde{{{\mbox{ADC}}}}\) | 0.60 (0.58) | 50–71 (49–66) | 0.85 (0.85) | 67 (62) | 54 (55) |
ACE | 0.61 (0.59) | 51–71 (51–67) | 3.4 (4.3) | 67 (44) | 57 (75) |
\(\widetilde{{{\mbox{K}}}}\)trans | 0.68 (0.70) | 58–78 (63–78) | 4.7 (4.7) | 53 (51) | 82 (84) |
PSMA | 0.72 (0.79) | 63–82 (72–86) | 6.5 (6.5) | 63 (68) | 82 (87) |
MRI2 | 0.66 (0.61) | 57–76 (53–69) | – | – | – |
MRI3 | 0.70 (0.70) | 61–80 (63–78) | – | – | – |
PSMA + MRI3 | 0.79 (0.82) | 71–87 (76–88) | – | – | – |